Research progress of the relationship between S100A8 and S100A9 and coronary heart disease
Author:
Affiliation:

1.Department of Cardiology, First Affiliated Hospital of Lanzhou University, Lanzhou Gansu730000, China;2.Key Laboratory of Cardiovascular Disease, Lanzhou, Gansu 730000, China)

Clc Number:

R543

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    S100A8 and S100A9, as endogenous risk-associated molecular patterns, recognize Toll-like receptor 4 and advanced glycation end product receptors, participate in immune response, change endothelial permeability and promote inflammation within the plaque, which affects the development of atherosclerosis. In addition, the elevated plasma levels of S100A8 and S100A9 are associated with an increased risk of future cardiovascular events. This article reviews the research status of S100A8 and S100A9 and their application prospects in the prevention, treatment and prognosis evaluation with coronary heart disease.

    Reference
    Related
    Cited by
Get Citation

WANG Runqing, WANG Yongxiang, ZHANG Zheng. Research progress of the relationship between S100A8 and S100A9 and coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(7):641-644.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 25,2020
  • Revised:November 17,2020
  • Online: June 28,2021
Article QR Code